OTCM
IOFNF
Market cap139mUSD
Oct 08, Last price
0.76USD
1D
-0.85%
1Q
2.70%
IPO
-55.60%
Name
Iofina PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Iofina plc is an enterprise primarily focused on the procurement and fabrication of iodine, alongside its specialized chemical derivatives. The company also handles produced water and natural gas resources. Its operational footprint spans across both the United States and the United Kingdom. A diverse array of products is offered by Iofina, encompassing halogen compounds, sanitizers, electronic specialty gases, preservatives, heat stabilizers, and various intermediate chemicals. Beyond these, their offerings extend to solutions for animal well-being, mineral refinement, and scent management. These essential products cater to a broad spectrum of sectors, including the electronics and semiconductor industry, pharmaceuticals, food and beverage production, personal hygiene, paints and coatings, dairy processing, chemical manufacturing, gemology, wildlife management, and the nylon industry. Moreover, Iofina extends its expertise by supplying all-encompassing, fee-based solutions to external operators of brine streams, facilitating the efficient extraction of iodine. The company originated in 2005 and maintains its principal offices in London, United Kingdom.
Related entities
Subsidiaries (4)
Iofina, Inc.
IOFINA CHEMICAL, INC.
Iofina Resources, Inc.
IofinaEX Inc.
Key people
Thomas Matthew Becker
President, Chief Executive Officer, Executive Director · since 2014
Malcolm Thomas Lewin
Chief Financial Officer, Executive Director · since 2016
William Delaney Bellamy
Non-Executive Director · since 2014
Frank Mermoud
Non-Executive Director · since 2018
Legal address
C/O KEYSTONE LAW (ATTN: SIMON HOLDEN)
48 CHANCERY LANE
LONDON, LND WC2A 1JF
GB
48 CHANCERY LANE
LONDON, LND WC2A 1JF
GB
Headquarters
8480 EAST ORCHARD ROAD
SUITE 4900
GREENWOOD VILLAGE, CO 80111
US
SUITE 4900
GREENWOOD VILLAGE, CO 80111
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||